DIGIPHARM - value-based health for living using blockchain technology

Wednesday, March 21, 2018

It's no secret that the healthcare and pharmaceutical industries are being undermined. Drug prices and health care costs continue to skyrocket, patients' conditions and treatments become increasingly complex, but efforts to lower costs seem to remain stagnant.
The inherent weaknesses of the current global healthcare infrastructure result in substantial inefficiencies, waste and health outcomes for the most important stakeholders; patient. In the current field of health, there is a lack of incentives for health systems and providers to focus on mutually beneficial collaborations and maximize patient outcomes. Most would agree that a sensible solution to this striking problem would be to adopt other innovative pricing models, such as value-based pricing.

What are a Fees for Service Prices
In the cost of the service system, service providers are given an incentive to provide more care and prescribe more drugs, at the expense of the patient. In addition, healthcare systems are often needed to make tough decisions about whether to reimburse pharmacological therapeutic costs and provide access to patients taking into account their limited resources. This resulted in rejected new pharmacologic therapy for the neediest patients, a missed opportunity to reduce the economic burden and long-term disease of the health system, and a barrier to reimbursement for producers.

As costs continue to increase and resources become more limited, one thing becomes clear - the healthcare industry as a whole will reach its peak because the model is unsustainable.

What is a Value-Based Price
In the simplest terms, value-based health services focus on price based on patient outcomes compared to volume.
The healthcare industry is experiencing a paradigm shift to value-based care because of growing demand, aging populations, chronic illness and unsustainable health-related spending levels. The health system is transitioning towards value-based care to prevent rationing of services and increasing costs for patients and payers without sacrificing quality of care. The provision of health care from a value-based perspective is based on the underlying goal of producing optimal patient outcomes relative to monetary outlays. Value-based pricing agreements are one of a series of options in a range of innovative pricing solutions. Ultimately, this solution is set up with the goal of providing access to the right medicine, at the right time to the patient and at the right cost to the health care system and the manufacturer.

The Future of Health Care
Health systems around the world today are threatened by unique challenges to our day; unsustainable spending, an aging population and an increasing prevalence of chronic diseases. The concept of value-based health services suggests that payments for health care should be linked to the quality of care and benefits it provides; switch from 'fee for service' to the 'fee for performance' replacement model.

Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty surrounding the relative costs of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivize innovation and drive the transition to patient-centered healthcare

Innovative proof generation solutions are needed to meet relevant, timely and quality data needs to inform optimized value-based health services delivery. Avoiding the use of static or retrospective data will open the horizons for superior forecasting, confidence in decision making and global oversight related to current developments in increasingly dynamic industries such as healthcare.

Our Excellence Solutions
The Reimburse platform utilizes the benefits of automated 'smart contracting' and blockchain technology; facilitate the adoption of a truly dynamic innovative pricing solution between health care systems and producers, in a safe and secure manner with the minimal administrative burden. The use of the Reimburse platform will accelerate the integration, coordination, and delivery of a centralized patient health care system with a focus on improving patient outcomes while accelerating payment mechanisms for value between payers and producers using neutral enforced agreements in peer to peer mode.

Pre-approval, personalized, contract terms will be encoded on the Reimburse platform through an easily accessible user interface and automatically executed when contract conditions are met. Reimbursement will also enable the implementation of some pricing conditions in the same agreement using intelligent contract technology, thus providing an increasingly dynamic and personalized pricing solution while passing through the current infrastructure constraints. The dynamic nature of Reimburse will allow health care systems and manufacturers to manage and monitor their budgets more effectively than is possible today.

Token Digipharm DPH
Digipharm DPH tokens will be used to pay license/access fees on the Digipharm platform. Access fees will be determined and specified in USD value and a token amount what is needed will depend on the type of access (producer, patient, payer or provider) combined with the required form of interaction. The number of tokens required for such interactions may change, relative to the market value of the DPH.

The characteristics of the DPH token
»DPH Supply: 100,000,000 Fixed (ERC-20)
»Code Ticker: DPH
»Decimal Place: 18
»Price Token 1.00 USD

Sales information of DPH token
»Pre - Sales: 15,000,000 DPH
»Basic Price: 1.00 USD
»Pre - Sales Duration: 4 Weeks
»Pre-Sales Discount: 35%
»Main Sale: 50.000.000 DPH

Funding the use and distribution of tokens

For more information please below: 

Share This :